MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 29 - per page Next page
Order by
Patented technology regarding new and safe mechanism with the active substance PH3 for the indications of osteoporosis and diabetic vascular complications. More
A number of specific PPLs, a group of prenylflavanone compounds, some novel, were isolated, identified and tested at as low as 0.04 μg/mL to be able to increase survival of neural stem cells, to promote neuronal growth with lengthening of neurite More
This technology is related to optimal conditions for culturing stem cells and feeder cells More
Two new compounds having HDAC (histone deacetylase) inhibition capability have shown the effect of inducing re-differentiation of human brain and breast cancer cells both in vitro and in vivo. More
The present invention relates to methods comprising of specialized mononuclear cells from bone marrow that can rescue hyperglycemia and augment pancreatic repair. More
Novel methods of cell culture for production of human parvovirus B19 (B19). These specific cell lines demonstrate limited infectability and commonly produce little or no virus following initial inoculation with B19. More
Methods of Inducing Differentiation In Stem Cells, Methods of Generating Tissue Using Scaffold Matrices Derived from Micro-Organs and Stem Cells, Methods of Producing Adult Stem Cells and Method S of Continuously Generating Stem Cells By Implantation More
The technology involves the characterization and identification of pulmonary stem cells as a target for viral infection. Application includes respiratory infection cell model, respiratory infection drug screening, lung tissue regenerative therapy More
Growing mesenchymal stem cells that retain their undifferentiated properties More
Patented solution technology capable of preserving and culturing any cell in the human body presents a unique opportunity to impact cellular therapy, vaccine production, regenerative medicine and organ preservation. More
Displaying 1..10 of 29 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us